Correlation Between Lantern Pharma and Pharvaris
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Pharvaris BV, you can compare the effects of market volatilities on Lantern Pharma and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Pharvaris.
Diversification Opportunities for Lantern Pharma and Pharvaris
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lantern and Pharvaris is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Pharvaris go up and down completely randomly.
Pair Corralation between Lantern Pharma and Pharvaris
Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the Pharvaris. In addition to that, Lantern Pharma is 1.01 times more volatile than Pharvaris BV. It trades about -0.1 of its total potential returns per unit of risk. Pharvaris BV is currently generating about 0.07 per unit of volatility. If you would invest 1,677 in Pharvaris BV on September 2, 2024 and sell it today you would earn a total of 513.00 from holding Pharvaris BV or generate 30.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lantern Pharma vs. Pharvaris BV
Performance |
| Timeline |
| Lantern Pharma |
| Pharvaris BV |
Lantern Pharma and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lantern Pharma and Pharvaris
The main advantage of trading using opposite Lantern Pharma and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Eliem Therapeutics | Lantern Pharma vs. Inhibrx | Lantern Pharma vs. Enliven Therapeutics |
| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. MediciNova | Pharvaris vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |